Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
454
datasets available to search
ShareScore release 0.9.0
Dataset results
454 results for “Tamoxifen”
Uterine Cavity Assessment and Endometrial Gene Expression in Tamoxifen Treated Breast Cancer Patients
ClinicalTrials.gov study NCT02311647. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02
ClinicalTrials.gov study NCT00963417. IPD Sharing: NO. Countries: 3. Publications: 0.
Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor Therapy
ClinicalTrials.gov study NCT00784888. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen
ClinicalTrials.gov study NCT00305838. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy
ClinicalTrials.gov study NCT00727948. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients
ClinicalTrials.gov study NCT03931928. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
ClinicalTrials.gov study NCT00492687. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Concurrent Versus Sequential Tamoxifen With Radiotherapy in Breast Cancer Patients
ClinicalTrials.gov study NCT00896155. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Pharmacogenomics Differences in Phase I and II Metabolism of Tamoxifen on Efficacy and Toxicity
ClinicalTrials.gov study NCT00886535. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer
ClinicalTrials.gov study NCT00993642. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors
ClinicalTrials.gov study NCT03707340. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Trial to Evaluate the Safety and Effectiveness of GDC-0032 When Given Alongside Tamoxifen
ClinicalTrials.gov study NCT02285179. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
ClinicalTrials.gov study NCT00096369. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase III, Randomized, Double Blind Trial Low Dose Tamoxifen Versus Placebo in Hormone Replacement Therapy (HRT) Users
ClinicalTrials.gov study NCT01579734. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Biological Response to Tamoxifen (TAM) in Patients With Breast Cancer Non Metastatic RH+
ClinicalTrials.gov study NCT01220076. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer
ClinicalTrials.gov study NCT00569543. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Investigating the Impact of Tamoxifen Therapy on Ovarian Aging
ClinicalTrials.gov study NCT01384526. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing Low Dose Tamoxifen for Invasive Breast Cancer, the (LoTam) Trial
ClinicalTrials.gov study NCT06671912. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376
ClinicalTrials.gov study NCT04961632. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen
ClinicalTrials.gov study NCT04080297. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.